Related Experiment Videos

Dickkopf-1 is down-regulated by MYCN and inhibits neuroblastoma cell proliferation

Arjen Koppen1, Rachida Ait-Aissa, Saskia Hopman

  • 1Department of Human Genetics, Academic Medical Center, University of Amsterdam, P.O. Box 22700, 1100 DE Amsterdam, The Netherlands.

Cancer Letters
|July 24, 2007
PubMed

Insights

MYCN oncogene amplification in neuroblastoma suppresses Dickkopf-1 (DKK1) expression. DKK1 inhibits neuroblastoma cell proliferation, potentially via SYNPO2, suggesting a new therapeutic target for this pediatric cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Developmental Biology

Background:

  • Neuroblastomas are pediatric cancers originating from the neural crest.
  • MYCN oncogene amplification occurs in 20% of neuroblastomas, correlating with poor prognosis.
  • MYCN acts as a transcription factor, regulating both gene activation and repression.

Purpose of the Study:

  • To identify genes repressed by MYCN in neuroblastoma.
  • To investigate the role of Dickkopf-1 (DKK1) in MYCN-driven neuroblastoma.
  • To explore potential therapeutic strategies targeting the MYCN-DKK1 axis.

Main Methods:

  • Gene expression profiling of neuroblastoma cell lines with regulated MYCN activity (SHEP-21N, SKNAS-NmycER).
  • Generation of a DKK1-inducible neuroblastoma cell line (IMR32-DKK1).
  • Analysis of gene expression changes upon DKK1 induction.

Main Results:

  • MYCN was found to suppress DKK1 expression in neuroblastoma cells.
  • DKK1 expression impaired neuroblastoma cell proliferation.
  • DKK1's growth suppressive effect may involve alternative Wnt pathway signaling and SYNPO2 induction.

Conclusions:

  • MYCN may promote neuroblastoma proliferation by down-regulating DKK1.
  • DKK1, potentially through SYNPO2, exhibits anti-proliferative effects in neuroblastoma.
  • Targeting the MYCN-DKK1 pathway presents a potential therapeutic avenue for neuroblastoma.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...